Mehdi Najafzadeh


 

 

About the Student

E-mail: mehdin@interchange.ubc.ca
Phone: 604-822-7694
Fax: 604-822-7694

Training

Degree: MA, Economics
Institution: University of British Columbia
Period: 2005
Degree: MSc, Socio-economic systems
Institution: IRPD, Tehran
Period: 2001
Degree: BSc, Electrical Engineering
Institution: Sharif University of Technology, Tehran
Period: 1997

Current Position

Position: Ph.D. candidate
Research Group: Faculty of Pharmaceutical Sciences, University of British Columbia, (In progress)
Supervisors: Dr. Carlo Marra and Dr. Larry Lynd

Scholarships + Awards

Name: CIHR Frederick Banting and Charles Best Canada Graduate Scholarship PhD award
Organization: Canadian Institutes of Health Research
Name: Four-Year Fellowship (FYF)  
Organization: University of British Columbia
Name: Graduate Entrance Scholarship
Organization: University of British Columbia
Tenure period: 2007

Links

http://www.core.ubc.ca/~salma/core/about.php?id=8
http://www.cheos.ubc.ca/aboutus/index.php?section=aboutus&page=popup&id=111

About The Research

My doctoral thesis is focused on measuring preferences of the public and of physicians towards new genetic tools and personalized medicine. My research area is health outcomes evaluation and health economics.

Publications + Presentations

Published Papers
  • Najafzadeh M, Marra CA, Galanis E, Patrick DM. Cost effectiveness of herpes zoster vaccine in Canada. Pharmacoeconomics. 2009;27(12):991-1004.
  • Davis JC, Marra CA, Najafzadeh M, Liu-Ambrose T. The independent contribution of executive functions to health related quality of life in older women. BMC Geriatr. 2010 Apr 1;10:16.
  • Lynd LD, Najafzadeh M, Colley L, Byrne MF, Willan AR, Sculpher MJ, Johnson FR, Hauber AB. Using the Incremental Net Benefit Framework for Quantitative Benefit-Risk Analysis in Regulatory Decision-Making-A Case Study of Alosetron in Irritable Bowel Syndrome. Value Health. 2009 Sep 10.
  • Najafzadeh M, Marra CA, Sadatsafavi M, Aaron SD, Sullivan SD, Vandemheen KL, Jones PW, Fitzgerald JM. Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Thorax. 2008 Nov;63(11):962-7.
  • Najafzadeh M, Sadatsafavi M, Marra CA. Interpretation of results of the cost-effectiveness analysis reported by Pellissier et al. on October 2007. Vaccine. 2008 Sep 26;26(41):5244; author reply 5245. Epub 2008 Jul 9.
  • Karissa MJ, Marra CA, Connors JM, Najafzadeh M, Sehn L, Peacock SJ. Cost-effectiveness of the addition of rituximab to CHOP chemotherapy in first-line treatment for diffuse large B-cell lymphoma in a population-based observational cohort in British Columbia, Canada. Value in Health. July 2010 Volume 13 Issue 6.
Oral presentations
  • Najafzadeh M, Marra CA. Barriers for integrating genomics and personalized medicine into clinical practice. GenOMICS – Today and Tomorrow’s Medicine, BC Clinical Genomics Network Annual Conference (Continuing Medical Education Workshop). Vancouver (April, 30 2010).
  • Najafzadeh M, Marra CA, Galanis E, Patrick D. The Cost-effectiveness of Herpes Zoster Vaccine in Canada. The Centre for Clinical Epidemiology & Evaluation Rounds, Vancouver, April 06, 2009.
  • Najafzadeh M, Marra CA, Galanis E, Patrick D. The Cost-effectiveness of Herpes Zoster Vaccine. INFORMS annual meeting November 4-7 2007, Seattle, Washington. Oral Presentation in the “Operations Research in Medicine and Health Care” cluster, November 4-7, 2007.

 

« Back



a place of mind, The University of British Columbia

Faculty of Pharmaceutical Sciences
2405 Wesbrook Mall
Vancouver, BC, Canada V6T 1Z3
Tel (Dean’s Office): 604.822.2343

Emergency Procedures | Accessibility | Contact UBC | © Copyright The University of British Columbia